Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- University of Southern California
- Study ID
- NCT06171607
- Phase
- PHASE1
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Contrast-Enhanced Ultrasound — PROCEDUREUndergo CEUS
- Perflutren Lipid Microspheres — DRUGGiven IV
- Sulfur Hexafluoride Lipid Microspheres — DRUGGiven IV
Study Details
This clinical trial investigates the role of contrast enhanced ultrasound (CEUS) in identifying cystic breast masses as benign or malignant. Ultrasound is a diagnostic imaging test that uses sound waves to make pictures of the body without using radiation (x-rays). Ultrasounds are widely used to diagnose many diseases in the body. This trial may help researchers learn if using CEUS will help in determining whether or not an ultrasound guided biopsy is necessary.
Key Dates
- Start date
- Nov 5, 2020
- Status verified
- Jan 2026
- Primary completion
- Nov 5, 2026
- Completion
- Nov 5, 2027
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: Diagnostic (contrast agent, CEUS)Patients receive a contrast tracer (Lumason or DEFINITY) IV and then undergo CEUS scan over 60-90 minutes.
Primary Outcome Measure
Radiomics-based ML-classifier framework [ Time Frame: Up to 12 months ]
Central Contacts
- Janet Jaime323-865-3205
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Los Angeles County-USC Medical Center | Los Angeles | California | 90033 | Bino A. Varghese, PhD (PRINCIPAL_INVESTIGATOR) |
| USC / Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | Bino A. Varghese, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Los Angeles, CA
By condition
By specialty
Related Studies
- Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast CancerRecruiting · City of Hope Medical Center · Duarte, California
- Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast CancerPHASE2 · Recruiting · National Cancer Institute (NCI) · Duarte, California
- Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible ParticipantsRecruiting · Jonsson Comprehensive Cancer Center · Los Angeles, California
- Mobile Health for Adherence in Breast Cancer PatientsRecruiting · ECOG-ACRIN Cancer Research Group · Fairbanks, Alaska